Identification of antisense nucleic acid hybridization sites in mRNA molecules with self-quenching fluorescent reporter molecules.
- Published in:
- Nucleic Acids Research, 2005, v. 33, n. 3, p. e28, doi. 10.1093/nar/gni024
- By:
- Publication type:
- Article
Works matching AU Opalinska, Joanna B.
Results: 6
1
2
A phase I, open-label, two-stage study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral AKT inhibitor GSK2141795 in patients with solid tumors.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 6, p. 1016, doi. 10.1007/s10637-018-0591-z
- By:
- Publication type:
- Article
3
Nucleic Acid Therapeutics for Hematologic Malignancies—Theoretical Considerations.
- Published in:
- Annals of the New York Academy of Sciences, 2006, v. 1082, n. 1, p. 124, doi. 10.1196/annals.1348.002
- By:
- Publication type:
- Article
4
Nucleic-acid therapeutics: basic principles and recent applications.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 7, p. 503, doi. 10.1038/nrd837
- By:
- Publication type:
- Article
5
Correction: The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
6
The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development.
- Published in:
- Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01212-0
- By:
- Publication type:
- Article